AB0418 Differences between clinical and laboratory findings in patients with recent diagnosis of sle according to the presence or absence of anti-dna antibodies by crithidia luciliae

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A915.3-A916
Author(s):  
M. I. Sarbu ◽  
P. Rubio Muñoz ◽  
T. C. Salman Monte ◽  
J. G. Lopéz Velandia ◽  
J. Pérez-Ruiz ◽  
...  
Lupus ◽  
2015 ◽  
Vol 24 (11) ◽  
pp. 1198-1203 ◽  
Author(s):  
M I Sarbu ◽  
T C Salman-Monte ◽  
P Rubio Muñoz ◽  
M P Lisbona ◽  
M Almirall Bernabé ◽  
...  

1998 ◽  
Vol 188 (5) ◽  
pp. 985-990 ◽  
Author(s):  
Hanno B. Richards ◽  
Minoru Satoh ◽  
Melody Shaw ◽  
Claude Libert ◽  
Valeria Poli ◽  
...  

Pristane induces a lupus-like syndrome in nonautoimmune mice characterized by the development of glomerulonephritis and lupus-associated autoantibodies. This is accompanied by overproduction of interleukin (IL)-6, a cytokine linked with autoimmune phenomena. The goal of this study was to evaluate the role of IL-6 in autoantibody production in pristane-induced lupus. BALB/cAn IL-6–deficient (−/−) and –intact (+/+) mice were treated with pristane or phosphate-buffered saline, and autoantibody production was evaluated. Pristane induced high levels of immunoglobulin (Ig)G anti-single-stranded DNA, –double-stranded (ds)DNA, and -chromatin antibodies in IL-6+/+, but not IL-6−/− mice by enzyme-linked immunosorbent assay. High titer IgG anti-dsDNA antibodies also were detected in sera from +/+, but not −/−, mice by Crithidia luciliae kinetoplast staining. The onset of IgG anti-dsDNA antibody production in +/+ mice occurred >5 mo after pristane treatment, well after the onset of nephritis, suggesting that these antibodies are not directly responsible for inducing renal disease. In contrast to anti-DNA, the frequencies of anti-nRNP/Sm and anti-Su antibodies were similar in pristane-treated IL-6−/− and IL-6+/+ mice. However, levels were higher in the +/+ group. These results suggest that IgG anti-DNA and chromatin antibodies in pristane-treated mice are strictly IL-6 dependent, whereas induction of anti-nRNP/Sm and Su autoantibodies is IL-6 independent. The IL-6 dependence of anti-DNA, but not anti-nRNP/Sm, may have implications for understanding the patterns of autoantibody production in lupus. Anti-DNA antibodies are produced transiently, mainly during periods of disease activity, whereas anti-nRNP/Sm antibody levels are relatively insensitive to disease activity. This may reflect the differential IL-6 dependence of the two responses.


Rheumatology ◽  
1988 ◽  
Vol 27 (3) ◽  
pp. 206-210 ◽  
Author(s):  
P. G. TIPPING ◽  
R. R. C. BUCHANAN ◽  
A. G. RIGLAR ◽  
W. J. DIMECH ◽  
G. O. LITTLEJOHN ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-12
Author(s):  
Nisen Abuaf ◽  
Chantal Desgruelles ◽  
Mohamed Moumaris ◽  
Faïza Boussa-Khettab ◽  
Hidayeth Rostane ◽  
...  

A new method for the detection by flow cytometry of anti-double-stranded DNA antibodies and of circulating immune complexes (IC) containing endogenous DNA (IC-eDNA) is described. From each serum sample, two samples were taken, one was used to detect IC-eDNA. The other to detect anti-DNA antibodies was incubated with calf thymus DNA. ICs were isolated by polyethylene glycol precipitation or by cryoprecipitation, after which immunoglobulins were labeled with FITC-conjugated anti-human globulin. Serum samples from 63 systemic lupus erythematosus (SLE) patients, 32 incomplete lupus, and 87 control patients were tested. Detection of anti-dsDNA antibodies by flow cytometry had a diagnostic sensitivity and specificity almost comparable to routine tests, the fluorescent enzyme immunoassay EliA™-dsDNA test, and the ultrasensitive Crithidia luciliae indirect immunofluorescence test. In 21 (33%) out of 63 SLE serum samples, IC-eDNA was detected. In these samples, free anti-dsDNA antibodies were hardly detectable or undetectable by flow cytometry or by routine tests. When anti-DNA antibodies are neutralized by endogenous DNA and can no longer be detected by routine tests, the serologic diagnosis and the follow-up of relapses in patients with SLE is compromised. To overcome this obstacle, we propose an accessible solution: the detection of circulating IC-eDNA by flow cytometry.


PEDIATRICS ◽  
1992 ◽  
Vol 89 (3) ◽  
pp. 441-444 ◽  
Author(s):  
David A. Cabral ◽  
Ross E. Petty ◽  
Marinda Fung ◽  
Peter N. Malleson

One Hundred eight children with musculoskeletal pain considered not to be due to an autoimmune or inflammatory disease had an antinuclear antibody (ANA) test performed. Twenty-four of these children were ANA positive on HEp-2 cell substrate at a screening serum dilution of 1:20. A positive ANA test persisted in 21 of 24 of the patients over a mean time period of 38 months (range 1 to 103 months). No sera from any patient at initial evaluation had anti-DNA antibodies by radioimmunoassay or by indirect immunofluorescence on Crithidia luciliae. One patient recently developed elevated anti-DNA (radioimmunoassay) antibodies but still has a negative assay on C luciliae. Four patients had antibodies to core histones by immunoblotting. None had antibodies to Sm, RNP, Ro (SS-A), or La (SS-B) by counterimmunoelectrophoresis. No patient developed an overt inflammatory or autoimmune disease during a mean follow-up period of 61 months (range 13 to 138 months). A child with musculoskeletal pain and a positive test for ANA, but with no clinical evidence at presentation of inflammatory or autoimmune disease, is at low risk of imminently developing such a disease.


Sign in / Sign up

Export Citation Format

Share Document